GLP-1s: The Medications Redefining Diabetes and Obesity Treatment Experts tackle access, equity, and the blockbuster drugs reshaping healthcare Dec 04, 2024 video
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up News and commentary from the endocrinology world Dec 03, 2024
Drug Prices Negotiated by Medicare Still Higher Than Other Countries' All drugs except one remained more expensive in the U.S. Dec 02, 2024
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome News and commentary from the endocrinology world Nov 26, 2024
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
CGM Uptake Very Low for Vulnerable Diabetes Populations But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
Metformin Use Linked to Fewer Asthma Attacks Addition of GLP-1 drugs led to an even greater reduction Nov 19, 2024
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data? News and commentary from the endocrinology world Nov 19, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose Nov 18, 2024 video
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Multiple Chronic Conditions and Death; Diabetes Treatment for Gout Also in TTHealthWatch: frailty as a predictor of dementia Nov 16, 2024 podcast
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge News and commentary from the endocrinology world Nov 12, 2024
Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filters Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promise Ophthalmologists hope expanded use will lead to more evaluations in primary clinics Nov 08, 2024
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer Health news and commentary gathered by 番茄社区app staff Nov 08, 2024
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down News and commentary from the endocrinology world Nov 05, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia Also in TTHealthWatch: best medications for opioid use disorder Oct 26, 2024 podcast
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis Large observational study suggests further research is warranted Oct 24, 2024
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients Findings leave researcher "concerned" Oct 23, 2024
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids News and commentary from the endocrinology world Oct 22, 2024
No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
Serious Battery Issue Prompts Medtronic Insulin Pump Recall Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer News and commentary from the endocrinology world Oct 15, 2024
CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Disease Plus: nalbuphine for IPF cough and AI for reducing lung allograft discards Oct 14, 2024
Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia News and commentary from the endocrinology world Oct 08, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D News and commentary from the endocrinology world Oct 01, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Risk Also in TTHealthWatch: AACR report on cancer Sep 28, 2024 podcast
